Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.11 billion. The enterprise value is $1.73 billion.
| Market Cap | 1.11B |
| Enterprise Value | 1.73B |
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 50.16 million shares outstanding. The number of shares has increased by 2.59% in one year.
| Current Share Class | 50.16M |
| Shares Outstanding | 50.16M |
| Shares Change (YoY) | +2.59% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 12.53% |
| Owned by Institutions (%) | 53.73% |
| Float | 37.71M |
Valuation Ratios
The trailing PE ratio is 112.97 and the forward PE ratio is 21.07. Astrana Health's PEG ratio is 0.63.
| PE Ratio | 112.97 |
| Forward PE | 21.07 |
| PS Ratio | 0.37 |
| Forward PS | 0.28 |
| PB Ratio | 1.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.42 |
| P/OCF Ratio | 10.39 |
| PEG Ratio | 0.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.58, with an EV/FCF ratio of 17.85.
| EV / Earnings | 181.48 |
| EV / Sales | 0.60 |
| EV / EBITDA | 14.58 |
| EV / EBIT | 21.30 |
| EV / FCF | 17.85 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 1.96.
| Current Ratio | 1.40 |
| Quick Ratio | 1.36 |
| Debt / Equity | 1.96 |
| Debt / EBITDA | 8.14 |
| Debt / FCF | 11.21 |
| Interest Coverage | 2.01 |
Financial Efficiency
Return on equity (ROE) is 1.83% and return on invested capital (ROIC) is 3.87%.
| Return on Equity (ROE) | 1.83% |
| Return on Assets (ROA) | 2.88% |
| Return on Invested Capital (ROIC) | 3.87% |
| Return on Capital Employed (ROCE) | 5.06% |
| Revenue Per Employee | $1.52M |
| Profits Per Employee | $5,019 |
| Employee Count | 1,900 |
| Asset Turnover | 1.64 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $20.47 million in taxes.
| Income Tax | 20.47M |
| Effective Tax Rate | 67.76% |
Stock Price Statistics
The stock price has decreased by -49.17% in the last 52 weeks. The beta is 0.87, so Astrana Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -49.17% |
| 50-Day Moving Average | 27.76 |
| 200-Day Moving Average | 28.03 |
| Relative Strength Index (RSI) | 36.45 |
| Average Volume (20 Days) | 598,309 |
Short Selling Information
The latest short interest is 2.38 million, so 4.75% of the outstanding shares have been sold short.
| Short Interest | 2.38M |
| Short Previous Month | 2.01M |
| Short % of Shares Out | 4.75% |
| Short % of Float | 6.32% |
| Short Ratio (days to cover) | 4.74 |
Income Statement
In the last 12 months, Astrana Health had revenue of $2.90 billion and earned $9.54 million in profits. Earnings per share was $0.20.
| Revenue | 2.90B |
| Gross Profit | 296.97M |
| Operating Income | 81.25M |
| Pretax Income | 30.21M |
| Net Income | 9.54M |
| EBITDA | 118.72M |
| EBIT | 81.25M |
| Earnings Per Share (EPS) | $0.20 |
Balance Sheet
The company has $463.45 million in cash and $1.09 billion in debt, giving a net cash position of -$623.80 million or -$12.44 per share.
| Cash & Cash Equivalents | 463.45M |
| Total Debt | 1.09B |
| Net Cash | -623.80M |
| Net Cash Per Share | -$12.44 |
| Equity (Book Value) | 554.72M |
| Book Value Per Share | 15.70 |
| Working Capital | 253.70M |
Cash Flow
In the last 12 months, operating cash flow was $106.54 million and capital expenditures -$9.57 million, giving a free cash flow of $96.96 million.
| Operating Cash Flow | 106.54M |
| Capital Expenditures | -9.57M |
| Free Cash Flow | 96.96M |
| FCF Per Share | $1.93 |
Margins
Gross margin is 10.25%, with operating and profit margins of 2.81% and 0.33%.
| Gross Margin | 10.25% |
| Operating Margin | 2.81% |
| Pretax Margin | 1.04% |
| Profit Margin | 0.33% |
| EBITDA Margin | 4.10% |
| EBIT Margin | 2.81% |
| FCF Margin | 3.35% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.59% |
| Shareholder Yield | -2.59% |
| Earnings Yield | 0.86% |
| FCF Yield | 8.76% |
Analyst Forecast
The average price target for Astrana Health is $43.00, which is 94.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $43.00 |
| Price Target Difference | 94.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 16.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 2.34 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.34 |
| Piotroski F-Score | 5 |